The Board has granted service connection for multiple myeloma, finding that the evidence is in equipoise and resolving all reasonable doubt in favor of the appellant.
The deciding factor: The private physician's opinion linking benzene exposure to the Veteran's responsibilities as an Abrams Armor Crewman during service resulted in a link between TERAs and multiple myeloma.
- Claimed conditions
- multiple myeloma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- April 29, 2026
- Citation
- A26039950
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A26039950.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's claim for an initial rating in excess of 100 percent for service-connected multiple myeloma has been denied. The Board also remanded two issues related to nerve neuropathies, and the claims for TDIU and SMC have been denied.
- Remanded (sent back)
The Board has remanded the claims for service connection for multiple myeloma and back problems due to a duty to assist error. For multiple myeloma, the Veteran's exposure to asbestos is not verified. For back problems, an addendum opinion is needed to consider the Veteran's lay statements regarding her training-related injuries.
- Granted
The Board has granted service connection for multiple myeloma, diabetes mellitus II, and coronary artery disease (CAD) based on the Veteran's in-service exposure to herbicide agents.
- Granted
The Veteran's claim for service connection for multiple myeloma has been granted, with a rating of 100 percent effective from August 10, 2022. The issue of service connection for plasmacytoma is remanded.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.